DELFI: DELFI Diagnostics CTO Dr. Amoolya Singh Recognized Among 2025 Most Influential Women in Bay Area Business
DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage cell-free DNA (cfDNA) fragmentomics for cancer detection and monitoring, today... Read More The post DELFI Diagnostics CTO Dr. Amoolya Singh Recognized Among 2025 Most Influential Women in Bay Area Business appeared first on citybiz.
Read full article »
Delfi is a Maryland-based biotechnology company that research and develops fluid biopsy tests for the early detection of cancer.
Read more